199 related articles for article (PubMed ID: 23666587)
1. Percutaneous nephrostomy for ureteric obstruction due to advanced pelvic malignancy: have we got the balance right?
Misra S; Coker C; Richenberg J
Int Urol Nephrol; 2013 Jun; 45(3):627-32. PubMed ID: 23666587
[TBL] [Abstract][Full Text] [Related]
2. The role of percutaneous nephrostomy in malignant ureteric obstruction.
Wilson JR; Urwin GH; Stower MJ
Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
[TBL] [Abstract][Full Text] [Related]
3. Nephrostomy insertion for patients with bilateral ureteric obstruction caused by prostate cancer.
Nariculam J; Murphy DG; Jenner C; Sellars N; Gwyther S; Gordon SG; Swinn MJ
Br J Radiol; 2009 Jul; 82(979):571-6. PubMed ID: 19153185
[TBL] [Abstract][Full Text] [Related]
4. Percutaneous nephrostomy in obstructing pelvic malignancy does not facilitate further oncological treatment.
Folkard SS; Banerjee S; Menzies-Wilson R; Reason J; Psallidas E; Clissold E; Al-Mushatat A; Chaudhri S; Green JSA
Int Urol Nephrol; 2020 Sep; 52(9):1625-1628. PubMed ID: 32319003
[TBL] [Abstract][Full Text] [Related]
5. Ureteric stents vs percutaneous nephrostomy for initial urinary drainage in children with obstructive anuria and acute renal failure due to ureteric calculi: a prospective, randomised study.
ElSheemy MS; Shouman AM; Shoukry AI; ElShenoufy A; Aboulela W; Daw K; Hussein AA; Morsi HA; Badawy H
BJU Int; 2015 Mar; 115(3):473-9. PubMed ID: 24698195
[TBL] [Abstract][Full Text] [Related]
6. Use of percutaneous nephrostomy in malignant ureteric obstruction.
Chapman ME; Reid JH
Br J Radiol; 1991 Apr; 64(760):318-20. PubMed ID: 2025771
[TBL] [Abstract][Full Text] [Related]
7. Role of percutaneous nephrostomy (PCN) in malignant ureteral obstruction.
Jalbani MH; Deenari RA; Dholia KR; Oad AK; Arbani IA
J Pak Med Assoc; 2010 Apr; 60(4):280-3. PubMed ID: 20419970
[TBL] [Abstract][Full Text] [Related]
8. Use of nephrostomy tubes in ureteric obstruction from incurable malignancy.
Little B; Ho KJ; Gawley S; Young M
Int J Clin Pract; 2003 Apr; 57(3):180-1. PubMed ID: 12723719
[TBL] [Abstract][Full Text] [Related]
9. The management of ureteric obstruction secondary to malignant pelvic disease.
Chitale SV; Scott-Barrett S; Ho ET; Burgess NA
Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538
[TBL] [Abstract][Full Text] [Related]
10. Clinical Factors Associated With a Short Survival Time After Percutaneous Nephrostomy for Ureteric Obstruction in Cancer Patients: An Updated Model.
Alawneh A; Tuqan W; Innabi A; Al-Nimer Y; Azzouqah O; Rimawi D; Taqash A; Elkhatib M; Klepstad P
J Pain Symptom Manage; 2016 Feb; 51(2):255-61. PubMed ID: 26497918
[TBL] [Abstract][Full Text] [Related]
11. Re: Percutaneous nephrostomy for malignant ureteric obstruction: have we got the balance right?
Bissada NK; Kamel MH
Int Urol Nephrol; 2013 Jun; 45(3):633. PubMed ID: 23666586
[No Abstract] [Full Text] [Related]
12. Percutaneous nephrostomy in the management of malignant ureteric obstruction.
Teenan RP; Ramsay A; Deane RF
Br J Urol; 1989 Sep; 64(3):238-40. PubMed ID: 2804559
[TBL] [Abstract][Full Text] [Related]
13. Percutaneous nephrostomies.
Kehinde EO; Newland CJ; Terry TR; Watkin EM; Butt Z
Br J Urol; 1993 Jun; 71(6):664-6. PubMed ID: 8343890
[TBL] [Abstract][Full Text] [Related]
14. Self-expanding wallstent endoprosthesis for malignant ureteral obstruction.
Díaz-Lucas EF; Martínez-Torres JL; Fernández Mena J; Carazo Martínez O; de la Fuente Serrano A; Zuluaga Gómez A
J Endourol; 1997 Dec; 11(6):441-7. PubMed ID: 9440854
[TBL] [Abstract][Full Text] [Related]
15. The role of percutaneous nephrostomy in malignant urinary tract obstruction.
Watkinson AF; A'Hern RP; Jones A; King DM; Moskovic EC
Clin Radiol; 1993 Jan; 47(1):32-5. PubMed ID: 8428414
[TBL] [Abstract][Full Text] [Related]
16. Re-evaluation of indications for percutaneous nephrostomy and interventional uroradiological procedures in pelvic malignancy.
Hoe JW; Tung KH; Tan EC
Br J Urol; 1993 Apr; 71(4):469-72. PubMed ID: 8499993
[TBL] [Abstract][Full Text] [Related]
17. Survival time and period of catheterization in patients treated with percutaneous nephrostomy for urinary obstruction due to malignancy.
Radecka E; Magnusson M; Magnusson A
Acta Radiol; 2006 Apr; 47(3):328-31. PubMed ID: 16613316
[TBL] [Abstract][Full Text] [Related]
18. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
[TBL] [Abstract][Full Text] [Related]
19. Are all urgent nephrostomies that urgent?
Koh D; Lau KK; Teoh E
Emerg Radiol; 2018 Aug; 25(4):381-386. PubMed ID: 29536275
[TBL] [Abstract][Full Text] [Related]
20. [Endo-urological drainage in urinary outflow obstruction caused by cancer].
Stevens A; van Driel MF; Klein JP; de Ruiter AJ; Mensink HJ
Ned Tijdschr Geneeskd; 1994 Mar; 138(10):522-5. PubMed ID: 8139712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
